Head-to-head · WeighScore
Ozari Health vs Primary Clinic (Direct GLP)
The verdict
Ozari Health takes it — 69.8/100 to 68.7/100, but only just.
Ozari Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ozari Health is a telehealth weight-loss platform offering physician-prescribed compounded GLP-1 from licensed pharmacies — semaglutide from $86/month and tirzepatide from around $149/month, with shipping… Primary Clinic (Direct GLP) is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ozari Health | Primary Clinic (Direct GLP) |
|---|---|---|
| WeighScore | 69.8/100 | 68.7/100 |
| Grade | C | C |
| Scorecard rank | #117 | #144 |
| Semaglutide | $86/mo (compounded) | $65/mo (0.25 mg dose, promotional rate, compounded) |
| Tirzepatide | $149/mo (compounded) | $110/mo (2.5 mg dose, promotional rate, compounded) |
| Coverage | Coverage not published | 10 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #117 · C
Strengths
- Very low entry pricing — compounded semaglutide from $86/month
- LegitScript certified and operated by a named entity (Ozari LLC)
- Board-certified physicians; meds compounded in 503A and 503B facilities
- Shipping included in the plan price
Where it loses points
- Doesn't clearly list which states it serves or name its pharmacies
- Tirzepatide and higher semaglutide doses cost more than the $86 headline
- Compounded semaglutide and tirzepatide only — no brand-name options
- Newer, lighter web presence than established competitors
Graded #144 · C
Strengths
- Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
- GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
- Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
- Routine labs and thousands of medications included in membership — no surprise bills
- Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide
Where it loses points
- 10 states only (WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA) — limited vs 50-state platforms
- Membership required to access wholesale pricing — $89/mo adds ~$1,068/yr in fixed cost
- 503A pharmacy partners not named
- LegitScript certification not mentioned on the site
- Medical director and corporate legal entity not disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.